These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
192 related items for PubMed ID: 20023190
1. Thromboelastometry to guide recombinant activated factor VII therapy for postoperative refractory intracranial bleeding. Hirasaki Y, Suematsu Y, Yasuda T, Tajima K. Anesth Analg; 2010 Jan 01; 110(1):261-2. PubMed ID: 20023190 [No Abstract] [Full Text] [Related]
2. Successful control of severe postoperative bleeding with recombinant factor VIIa in a case of refractory idiopathic thrombocytopenic purpura. Aguilar C, Lucía JF. Am J Hematol; 2007 Mar 01; 82(3):246-7. PubMed ID: 16924645 [No Abstract] [Full Text] [Related]
3. Successful treatment with recombinant factor VIIa for intractable bleeding at pelvic surgery. Daniloś J, Goral A, Paluszkiewicz P, Przesmycki K, Kotarski J. Obstet Gynecol; 2003 Jun 01; 101(6):1172-3. PubMed ID: 12798520 [Abstract] [Full Text] [Related]
4. [Application of recombinant activated factor VII in gynecological intervention (case report)]. Nacheva A, Gateva Zh, Atanasova V. Akush Ginekol (Sofiia); 2004 Jun 01; 43 Suppl 4():3-5. PubMed ID: 15673003 [No Abstract] [Full Text] [Related]
5. Rescue recombinant activated factor VII for neonatal subgaleal hemorrhage. Strauss T, Kenet G, Schushan-Eisen I, Mazkereth R, Kuint J. Isr Med Assoc J; 2009 Oct 01; 11(10):639-40. PubMed ID: 20077956 [No Abstract] [Full Text] [Related]
6. Recombinant activated factor VII (rFVIIa) treatment in infants with hemorrhage. Brady KM, Easley RB, Tobias JD. Paediatr Anaesth; 2006 Oct 01; 16(10):1042-6. PubMed ID: 16972833 [Abstract] [Full Text] [Related]
7. The utility of thromboelastography for guiding recombinant activated factor VII therapy for refractory hemorrhage after cardiac surgery. Wasowicz M, Meineri M, McCluskey SM, Mitsakakis N, Karkouti K. J Cardiothorac Vasc Anesth; 2009 Dec 01; 23(6):828-34. PubMed ID: 19467888 [Abstract] [Full Text] [Related]
8. Recombinant activated factor VII for hemorrhage after pediatric cardiac surgery. Singh SP, Chauhan S, Choudhary M, Vasdev S, Talwar S. Asian Cardiovasc Thorac Ann; 2012 Feb 01; 20(1):19-23. PubMed ID: 22371937 [Abstract] [Full Text] [Related]
9. Recombinant activated factor VII for intractable bleeding post splenectomy in a patient with myeloproliferative disorder. El Kinge AR, Mahfouz RA, Shamseddine AI, Taher AT. Blood Coagul Fibrinolysis; 2007 Sep 01; 18(6):577-9. PubMed ID: 17762536 [Abstract] [Full Text] [Related]
10. [Activated recombinant factor VII for bleeding after a kidney transplant: reflections]. Pajares A, Larrea L. Rev Esp Anestesiol Reanim; 2006 Apr 01; 53(4):266-7; author reply 268. PubMed ID: 16711505 [No Abstract] [Full Text] [Related]
11. [Treatment and prevention of haemorrhage with recombinant activated factor VII, not only in hemophilia]. Gielen-Wijffels SE, van Mook WN, Ramsay G. Ned Tijdschr Geneeskd; 2003 Mar 01; 147(9):419. PubMed ID: 12661464 [No Abstract] [Full Text] [Related]
12. Clinical significance of coagulation studies in predicting response to activated recombinant Factor VII in cardiac surgery patients. Lee AI, Campigotto F, Rawn JD, Neuberg D, Kaufman RM, Berliner N. Br J Haematol; 2012 May 01; 157(3):397-400. PubMed ID: 22224596 [No Abstract] [Full Text] [Related]
13. The use of recombinant-activated factor VII to successfully control postoperative critical bleeding after emergency repair of ruptured abdominal aortic aneurysm in a noncoagulopathic patient. Dell'Utri D, Passariello M. J Cardiothorac Vasc Anesth; 2006 Aug 01; 20(4):570-2. PubMed ID: 16884992 [No Abstract] [Full Text] [Related]
14. Recombinant activated factor VII in the management of massive obstetric bleeding. Palomino MA, Chaparro MJ, de Elvira MJ, Curiel EB. Blood Coagul Fibrinolysis; 2006 Apr 01; 17(3):226-7. PubMed ID: 16575264 [No Abstract] [Full Text] [Related]
15. Caution with the use of recombinant activated factor VII in treating postoperative hemorrhage in cardiac surgery. Al-Ruzzeh S, Mahmoud A, Shah S, O'Regan D. Ann Thorac Surg; 2007 Jan 01; 83(1):355; author reply 355-6. PubMed ID: 17184710 [No Abstract] [Full Text] [Related]
16. Elective surgery on factor VIII inhibitor patients using continuous infusion of recombinant activated factor VII: plasma factor VII activity of 10 IU/ml is associated with an increased incidence of bleeding. Smith MP, Ludlam CA, Collins PW, Hay CR, Wilde JT, Grigeri A, Melsen T, Savidge GF. Thromb Haemost; 2001 Oct 01; 86(4):949-53. PubMed ID: 11686351 [Abstract] [Full Text] [Related]
17. Relationship between factor VII activity and clinical efficacy of recombinant factor VIIa given by continuous infusion to patients with factor VIII inhibitors. Santagostino E, Morfini M, Rocino A, Baudo F, Scaraggi FA, Gringeri A. Thromb Haemost; 2001 Oct 01; 86(4):954-8. PubMed ID: 11686352 [Abstract] [Full Text] [Related]
18. The use of recombinant activated factor VII in three patients with central nervous system hemorrhages associated with factor VII deficiency. Huang WY, Kruskall MS, Bauer KA, Uhl L, Shaz BH. Transfusion; 2004 Nov 01; 44(11):1562-6. PubMed ID: 15504160 [Abstract] [Full Text] [Related]
19. Sequential therapy with activated prothrombin complex concentrate (FEIBA) and recombinant factor VIIa in a patient with severe haemophilia A, inhibitor presence and refractory bleeding. Economou M, Teli A, Tzantzaroudi A, Tsatra I, Zavitsanakis A, Athanassiou-Metaxa M. Haemophilia; 2008 Mar 01; 14(2):390-1. PubMed ID: 18194305 [No Abstract] [Full Text] [Related]
20. The danger of using a sledgehammer to crack a nut: ROTEM-guided administration of recombinant activated factor VII in a patient with refractory bleeding post-ventricular assist device implantation. Tarzia V, Buratto E, Bortolussi G, Paolini C, Bejko J, Bottio T, Gerosa G. Artif Organs; 2015 Mar 01; 39(3):248-53. PubMed ID: 25065398 [Abstract] [Full Text] [Related] Page: [Next] [New Search]